publication venue for
- Cytotoxicities of Tumor-Seeking Dyes: Impact on Future Clinical Trials.. 18:e202200561. 2023
- Drug Repurposing for the SARS-CoV-2 Papain-Like Protease.. 17:e202100455. 2022
- MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L.. 17:e202100456. 2022
- Front Cover: MPI8 is Potent against SARSCoV2 by Inhibiting Dually and Selectively the SARSCoV2 Main Protease and the Host Cathepsin L (ChemMedChem 1/2022). 17. 2022
- A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*.. 16:942-948. 2021
- PROTAC Compatibilities, Degrading Cell-Surface Receptors, and the Sticky Problem of Finding a Molecular Glue.. 16:316-318. 2021
- Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.. 14:1575-1579. 2019
- Covalent Inhibition in Drug Discovery.. 14:889-906. 2019
- Cover Feature: Covalent Inhibition in Drug Discovery (ChemMedChem 9/2019). 14:888-888. 2019
- N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity.. 11:687-701. 2016
- Polarization Transfer from Ligands Hyperpolarized by Dissolution Dynamic Nuclear Polarization for Screening in Drug Discovery.. 10:1559-1563. 2015
- Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead.. 7:1541-1545. 2012
- Triclosan derivatives: towards potent inhibitors of drug-sensitive and drug-resistant Mycobacterium tuberculosis.. 4:241-248. 2009
- Novel acyl phosphate mimics that target PlsY, an essential acyltransferase in gram-positive bacteria.. 3:1936-1945. 2008
- Reduction of lipophilicity at the lipophilic domain of RXR agonists enables production of subtype preference: RXRalpha-preferential agonist possessing a sulfonamide moiety.. 3:454-460. 2008